These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial. Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542 [TBL] [Abstract][Full Text] [Related]
12. [Subcutaneous panniculitis-like T-cell lymphoma: The authors' experience of diagnosis and treatment]. Gorodetskiy VR; Probatova NA; Vasilyev VI; Mukhortova OV; Aslanidi IP; Sidorova YV; Ryzhikova NV; Radenska-Lopovok SG; Egorova ON Ter Arkh; 2016; 88(7):49-55. PubMed ID: 27459615 [TBL] [Abstract][Full Text] [Related]
13. Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT. Seshadri N; Ananthasivan R; Kavindran R; Srikanth G; Chandra S Cancer Imaging; 2010 Oct; 10(1):194-7. PubMed ID: 20926362 [TBL] [Abstract][Full Text] [Related]
14. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging. Weijs LE; Arsos G; Baarslag HJ; Wittebol S; de Klerk JM Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624 [No Abstract] [Full Text] [Related]
15. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884 [TBL] [Abstract][Full Text] [Related]
16. The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma. Avigdor A; Sirotkin T; Kedmi M; Ribakovsy E; Berkowicz M; Davidovitz Y; Kneller A; Merkel D; Volchek Y; Davidson T; Goshen E; Apter S; Shimoni A; Ben-Bassat I; Nagler A Ann Hematol; 2014 Aug; 93(8):1297-304. PubMed ID: 24595734 [TBL] [Abstract][Full Text] [Related]
17. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy. Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801 [TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin Rash. Abe Y; Narita K; Kobayashi H; Kitadate A; Takeuchi M; Matsue K Clin Nucl Med; 2020 Feb; 45(2):e69-e71. PubMed ID: 31833924 [TBL] [Abstract][Full Text] [Related]
19. Utility of the PET-CT in the evaluation of early response to treatment in the diffuse large B-cell lymphoma. Preliminary results. Cortés Romera M; Gámez Cenzano C; Caresia Aróztegui AP; Martín-Comín J; González-Barca E; Ricart Brulles Y; Palacios Abufón A; Robles Barba J; Rodríguez-Bel L; Rossi Seoane S; Fernández de Sevilla A Rev Esp Med Nucl Imagen Mol; 2012; 31(3):135-41. PubMed ID: 21944191 [TBL] [Abstract][Full Text] [Related]
20. The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma. Park S; Moon SH; Park LC; Hwang DW; Ji JH; Maeng CH; Cho SH; Ahn HK; Lee JY; Kim SJ; Choi JY; Kim WS Am J Hematol; 2012 Sep; 87(9):937-40. PubMed ID: 22730093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]